SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'IH4'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O4N_A_TPVA300_2 (PROTEASE) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 5 / 8 | LEU A 168ALA A 20GLY A 122ILE A 123LEU A 8 | NoneNoneIH4 A1330 ( 3.9A)IH4 A1330 ( 4.4A)None | 1.27A | 2o4nB-2bjuA:6.2 | 2o4nB-2bjuA:13.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2V0Z_C_C41C1328_1 (RENIN) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 6 / 12 | ASP A 34GLY A 36SER A 37ASP A 214GLY A 216SER A 218 | IH4 A1330 (-4.2A)IH4 A1330 ( 4.6A)IH4 A1330 ( 4.6A)IH4 A1330 (-3.3A)IH4 A1330 ( 4.3A)IH4 A1331 (-3.9A) | 0.57A | 2v0zC-2bjuA:38.7 | 2v0zC-2bjuA:27.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2V0Z_O_C41O1327_1 (RENIN) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 5 / 12 | ASP A 34GLY A 36ASP A 214GLY A 216SER A 218 | IH4 A1330 (-4.2A)IH4 A1330 ( 4.6A)IH4 A1330 (-3.3A)IH4 A1330 ( 4.3A)IH4 A1331 (-3.9A) | 0.64A | 2v0zO-2bjuA:38.4 | 2v0zO-2bjuA:27.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W98_B_P1ZB1358_1 (PROSTAGLANDINREDUCTASE 2) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 4 / 6 | ASP A 214TYR A 192PHE A 305LEU A 197 | IH4 A1330 (-3.3A)IH4 A1330 (-4.0A)NoneNone | 1.09A | 2w98A-2bjuA:undetectable2w98B-2bjuA:undetectable | 2w98A-2bjuA:21.772w98B-2bjuA:21.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_Q_TFPQ201_1 (PROTEIN S100-A4) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 4 / 8 | GLY A 110PHE A 111ILE A 103PHE A 120 | NoneIH4 A1330 (-3.4A)NoneNone | 0.98A | 3ko0O-2bjuA:undetectable3ko0Q-2bjuA:undetectable | 3ko0O-2bjuA:12.863ko0Q-2bjuA:12.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PRS_A_RITA1001_2 (ENDOTHIAPEPSIN) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 5 / 12 | ASP A 34GLY A 36ASP A 214THR A 217ILE A 300 | IH4 A1330 (-4.2A)IH4 A1330 ( 4.6A)IH4 A1330 (-3.3A)IH4 A1331 ( 4.1A)IH4 A1330 (-4.5A) | 0.20A | 3prsA-2bjuA:35.4 | 3prsA-2bjuA:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PWW_A_ROCA1001_1 (ENDOTHIAPEPSIN) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 5 / 12 | ASP A 34PHE A 111ILE A 212THR A 217ILE A 300 | IH4 A1330 (-4.2A)IH4 A1330 (-3.4A)IH4 A1330 ( 4.0A)IH4 A1331 ( 4.1A)IH4 A1330 (-4.5A) | 0.72A | 3pwwA-2bjuA:35.4 | 3pwwA-2bjuA:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q70_A_RITA2001_1 (CANDIDAPEPSIN-2) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 6 / 12 | ILE A 32ASP A 34GLY A 36ASP A 214THR A 217ILE A 300 | IH4 A1330 (-4.1A)IH4 A1330 (-4.2A)IH4 A1330 ( 4.6A)IH4 A1330 (-3.3A)IH4 A1331 ( 4.1A)IH4 A1330 (-4.5A) | 0.29A | 3q70A-2bjuA:11.4 | 3q70A-2bjuA:26.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TNE_A_RITA401_1 (SECRETED ASPARTICPROTEASE) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 5 / 12 | ILE A 32ASP A 34GLY A 36ASP A 214ILE A 300 | IH4 A1330 (-4.1A)IH4 A1330 (-4.2A)IH4 A1330 ( 4.6A)IH4 A1330 (-3.3A)IH4 A1330 (-4.5A) | 0.28A | 3tneA-2bjuA:33.6 | 3tneA-2bjuA:23.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TNE_A_RITA401_1 (SECRETED ASPARTICPROTEASE) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 5 / 12 | ILE A 212ASP A 214GLY A 216ASP A 34ILE A 123 | IH4 A1330 ( 4.0A)IH4 A1330 (-3.3A)IH4 A1330 ( 4.3A)IH4 A1330 (-4.2A)IH4 A1330 ( 4.4A) | 0.80A | 3tneA-2bjuA:33.6 | 3tneA-2bjuA:23.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TNE_B_RITB401_1 (SECRETED ASPARTICPROTEASE) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 5 / 12 | ILE A 32ASP A 34GLY A 36ASP A 214ILE A 300 | IH4 A1330 (-4.1A)IH4 A1330 (-4.2A)IH4 A1330 ( 4.6A)IH4 A1330 (-3.3A)IH4 A1330 (-4.5A) | 0.31A | 3tneB-2bjuA:33.6 | 3tneB-2bjuA:23.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TNE_B_RITB401_1 (SECRETED ASPARTICPROTEASE) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 5 / 12 | ILE A 212ASP A 214GLY A 216ASP A 34ILE A 123 | IH4 A1330 ( 4.0A)IH4 A1330 (-3.3A)IH4 A1330 ( 4.3A)IH4 A1330 (-4.2A)IH4 A1330 ( 4.4A) | 0.82A | 3tneB-2bjuA:33.6 | 3tneB-2bjuA:23.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q5M_A_ROCA1101_3 (PROTEASE) |
2bju | PLASMEPSIN II (Plasmodiumfalciparum) | 3 / 3 | ASP A 214ASP A 34ASN A 39 | IH4 A1330 (-3.3A)IH4 A1330 (-4.2A)None | 0.84A | 4q5mA-2bjuA:8.9 | 4q5mA-2bjuA:18.53 |